Ligand Announces Proposed Offering of $225 Million of Convertible Senior … – PharmiWeb.com (press release)

Ligand Announces Proposed Offering of $225 Million of Convertible Senior
PharmiWeb.com (press release)
Upon conversion an amount up to the principal amount of the notes will be paid in cash and if applicable any premium above the principal amount will be paid in common stock or cash at Ligand’s discretion. … If the initial purchasers exercise their

and more

…read more

Scroll to Top